Skip to main content
Clinical Trials/NCT05975216
NCT05975216CompletedNot Applicable

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Universitair Ziekenhuis Brussel1 site in 1 country600 target enrollmentStarted: July 6, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
600
Locations
1
Primary Endpoint
Retrospective data collection

Study Overview

Brief Summary

Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up.

Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
  • ≥18 years

Exclusion Criteria

  • Positive HCV serology with negative HCV RNA
  • Previously eradicated patients in UZ Brussel

Outcomes

Primary Outcomes

Retrospective data collection

Time Frame: before contacting the patient

Prevalence of diagnosed but untreated HCV patients through positive serology with positive or unknown HCV RNA in UZ Brussel between 2012 - 2022.

Prospective interventional study

Time Frame: from first contact of the patient till 12 weeks after end of treatment.

To recall DBU patients by phone, e-mail or letter, trying to optimize treated and cured patients after recall

Secondary Outcomes

  • Reason lost in follow-up(from first contact of the patient till 12 weeks after end of treatment.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials